Are outcomes the same with all dry powder inhalers?

International Journal of Clinical Practice

Volumn 59, Issue SUPPL. 149, 2005, Pages 33-35

  Thomas, M ^a   Williams, Angela E ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma control; Beclometasone dipropionate; Database; DISKHALER ; Dry powder inhalers; Health outcomes; ROTAHALER

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; SHORT ACTING DRUG;

ASTHMA; CLINICAL TRIAL; DISEASE CONTROL; DRUG DELIVERY SYSTEM; DRY POWDER; EVIDENCE BASED MEDICINE; HUMAN; MAINTENANCE THERAPY; META ANALYSIS; METERED DOSE INHALER; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SELECTION; POWDER INHALER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

EID: 33845455651     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-504X.2005.00726.x     Document Type: Review

References (14)

1. Brocklebank D, Wright J, Cates C. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. BMJ 2001; 323: 896-900.
2. Lipworth BJ. Patients can't use pMDIs in real life. BMJ 2001. [Available at http://www.bmj.bmjjournals.com/cgi/eletters/323/7318/896].
3. Williams I. Cheapest best? BMJ 2001. [Available at http://www.bmj.bmjjournals.com/cgi/eletters/323/7318/896].
4. Senn S. Meta-analysis: More stress on analysis please. BMJ 2001. [Available at http://www.bmj.bmjjournals.com/cgi/eletters/323/7318/896].
5. Spiers R. Factual and methodological errors. BMJ 2001. [Available at http://www.bmj.bmjjournals.com/cgi/eletters/323/7318/896].
6. White PT. Systematic reviews of asthma inhalers - not generalisable without subject details. BMJ 2001. [Available at http://www.bmj.bmjjournals.com/cgi/eletters/323/7318/896].
7. Morice AH. Meta madness. BMJ 2001. [Available at http://www.bmj.bmjjournals.com/cgi/eletters/323/7318/896].
8. Everard M. Oh dear. BMJ 2001. [Available at http://www.bmj.bmjjournals.com/cgi/eletters/323/7318/896].
9. Thomas M, Cleland J, Price D. Database studies in asthma pharmacoeconomics: Uses, limitations and quality markers. Expert Opin Pharmacother 2003; 4: 1-8.
10. Mapel D, Pearson M. Obtaining evidence for use by healthcare payers on the success of chronic obstructive pulmonary disease management. Respir Med 2002; 96 (Suppl. C): S23-S30.
11. Herland K, Akselsen J-P, Skjønsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger 'real life' population of patients with obstructive lung disease? Respir Med 2005; 99: 11-9.
12. Duerden M, Price D. Training issues in the use of inhalers. Dis Manage Health Outcomes 2001; 9: 75-87.
13. Price D, Thomas M, Mitchell G et al. Improvement of asthma control with a breath-actuated pressurised metered dose inhaler (BAI): A prescribing claims study of 5556 patients using a traditional pressurised metered dose inhaler (MDI) or a breath- actuated device. Respir Med 2003; 97: 12-9.
14. Ayres JG, Kiri V, Holland PR, Spencer MD. The COPD patient's journey - newly diagnosed COPD patients in the UK Mediplus database. Eur Respir J 2004; 24(Suppl. 48): 143s and poster.